It's Official: Zoetis Belongs In Your Dividend Growth Portfolio
DG Ruralist - at Seeking Alpha - Mon Dec 22, 3:46PM CST
ZTS: 43.84 (+0.87), PFE: 31.42 (-0.03)
Zoetis: Betting The Proverbial Farm?
Marshall Hargrave - at Seeking Alpha - Sat Dec 20, 7:15AM CST
ZTS: 43.84 (+0.87), ABT: 45.70 (-0.02), MRK: 57.46 (+0.25), LLY: 70.16 (+0.42), NVS: 93.91 (+0.66)
An Exclusive Interview With Pershing Square's William (Bill) Ackman
Matt Stewart - at Seeking Alpha - Thu Dec 18, 8:30AM CST
ZTS: 43.84 (+0.87), AGN: 210.12 (+0.95), HLF: 37.98 (+0.20), VRX: 140.33 (-0.22), HHC: 133.21 (+0.49), PAH: 23.00 (+0.01), CP: 194.85 (-0.13), APD: 148.58 (unch), BKW: 35.50 (-1.16)
Today's Market: These Stocks Moving On News
Matthew Smith - at Seeking Alpha - Thu Dec 18, 8:17AM CST
ZTS: 43.84 (+0.87), HLF: 37.98 (+0.20), HTZ: 24.38 (-0.09), SNE: 21.32 (+0.46), AMC: 26.62 (-0.20), CKEC: 26.09 (+0.10), ORCL: 46.23 (+0.22), RGC: 21.20 (+0.09), CNK: 36.22 (+0.05)
Zoetis posts 15% improvement in Q1 2015 dividend
M2 - Thu Dec 18, 7:12AM CST
The board of directors of Zoetis (NYSE:ZTS), an animal health company, on Wednesday declared a dividend of USD0.083 per share of the company's common stock for the Q1 2015.
ZTS: 43.84 (+0.87)
Zoetis declares $0.08 dividend
Seeking Alpha - at Seeking Alpha - Thu Dec 18, 6:23AM CST
ZTS: 43.84 (+0.87)
Zoetis Declares First Quarter 2015 Dividend; Board Approves 15% Payment Increase
Business Wire - Wed Dec 17, 3:15PM CST
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a first quarter 2015 dividend payable to holders of the company's common stock of $0.083 per share, an increase of 15% from the quarterly dividend rate paid in 2014. The dividend is to be paid on Tuesday, Mar. 3, 2015, to holders of record on Thursday, Jan. 22, 2015.
ZTS: 43.84 (+0.87)
Why The Smart Money is Betting Billions On PetSmart
Rich Duprey, The Motley Fool - Motley Fool - Wed Dec 17, 2:32PM CST
Taking PetSmart private in one of the largest LBO's year-to-date may just be a prelude to a larger merger deal. PetSmart has been called to heel. The pet supplies giant agreed to be taken private by a group of investors led by PE firm BC...
ZTS: 43.84 (+0.87), AMZN: 303.03 (-3.26), PFE: 31.42 (-0.03), TGT: 74.65 (-0.04), WMT: 86.43 (-0.23), PETM: 81.16 (+0.03)
Better Big Pharma Spinoff: Zoetis Inc. or AbbVie Inc.?
Brian Orelli, The Motley Fool - Motley Fool - Wed Dec 17, 8:15AM CST
We're approaching two years after Abbott Labs spun off its pharmaceutical division AbbVie and a little less since Zoetis , Pfizer 's animal health division, separated from its patent company. Seems like a good time to see which spinoff...
ZTS: 43.84 (+0.87), ABT: 45.70 (-0.02), SHPG: 209.29 (+0.07), PFE: 31.42 (-0.03), ABBV: 66.21 (+1.86)
Zoetis to Participate in the 33rd Annual J.P. Morgan Healthcare Conference
Business Wire - Wed Dec 17, 7:29AM CST
Zoetis Inc.(NYSE:ZTS) will participate in the 33rd Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 14, in San Francisco, Calif. Juan Ramon Alaix, Chief Executive Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 1:00 p.m. EST (10:00 a.m. PST).
ZTS: 43.84 (+0.87), JPM: 62.48 (unch)
Top Investors Have Bought These 3 Stocks
Selena Maranjian, The Motley Fool - Motley Fool - Tue Dec 16, 12:00PM CST
Pershing Square's Bill Ackman is an influential investor. Image: Insider Monkey via Flickr. Every quarter, many hedge funds and other money managers have to disclose what they've bought and sold via "13F" filings. Their latest moves can shine a...
ZTS: 43.84 (+0.87), BIDU: 230.98 (-2.18), ORCL: 46.23 (+0.22)
Animal Feed Additives - Global Strategic Business Report
M2 - Tue Dec 16, 8:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/24vhpg/animal_feed) has announced the addition of the "Animal Feed Additives - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Animal Feed Additives in US$ Million by the following Product Segments: Antibiotics/Antibacterials, Vitamins, Antioxidants, Amino Acids, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 272 companies including many key and niche players such as: - ADDCON Group - Adisseo France SAS - Ajinomoto Co., Inc. - Alltech Inc. - Archer Daniels Midland Company Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS - Study Reliability and Reporting Limitations - Disclaimers - Data Interpretation & Reporting Level - Quantitative Techniques & Analytics - Product Definitions and Scope of Study - Product Definitions - Antibiotics/Antibacterials - Vitamins - Antioxidants - Amino Acids - Others II. EXECUTIVE SUMMARY 1. OUTLOOK 2. COMPETITIVE LANDSCAPE 3. MARKET TRENDS 4. PRODUCT OVERVIEW 5. REGULATORY & ENVIRONMENTAL ANALYSIS 6. PRODUCT INTRODUCTIONS/APPROVALS 7. RECENT INDUSTRY ACTIVITY 8. FOCUS ON SELECT GLOBAL PLAYERS - ADDCON Group - Adisseo France SAS - Ajinomoto Co., Inc - Ajinomoto Eurolysine S.A.S - Alltech Inc - Archer Daniels Midland Company - BASF SE - Biovet JSC - Cargill, Inc - Provimi Holding - Chr. Hansen - DSM Nutritional - DuPont - Elanco Animal Health - Evonik Industries AG (Germany) - InVivo NSA S.A. (France) - Kemin Industries, Inc. (US) - Lonza Group Ltd (Switzerland) - Novozymes A/S (Denmark) - Novus International, Inc. (US) - Nutreco N.V (the Netherlands) - Phibro Animal Health Corporation (US) - Tessenderlo Group (Belgium) - The Mosaic Company (US) - Zoetis, Inc. (US) 9. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. MIDDLE EAST/AFRICA 7. LATIN AMERICA IV. COMPETITIVE LANDSCAPE For more information visit http://www.researchandmarkets.com/research/24...nimal_feed
ZTS: 43.84 (+0.87), ADM: 53.11 (-0.06), PAHC: 28.70 (+0.54)
Cramer's Mad Money - Honeywell: The Optimistic Industrial (12/15/14)
SA Editor Miriam Metzinger - at Seeking Alpha - Tue Dec 16, 4:28AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Monday December 15. CEO interview: David Cote, Honeywell (NYSE: HON ) Honeywell ( HON ) is a diversified industrial which has been showing positives in areas...
ZTS: 43.84 (+0.87), WFM: 48.67 (-0.40), AA: 15.77 (+0.04), RVBD: 20.35 (+0.01), HON: 101.96 (-0.02), CHK: 19.84 (-0.45), APA: 64.05 (-1.38), MAR: 78.35 (-0.19), TWTR: 37.61 (+0.04), BABA: 105.95 (+0.43), PETM: 81.16 (+0.03)
Buffett and Billionaire Investors Look to Oil, Health Care and Spinoffs in 2015
at The Street - Mon Dec 15, 8:27AM CST
With 2014 nearly over, the question now becomes which stocks, sectors and strategies billionaire investors will be betting on in 2015. A few predictions.
VIPS: 19.95 (+0.41), ACT: 254.20 (-1.68), F: 15.30 (-0.03), TLM: 7.84 (unch), AXP: 94.08 (+0.26), ATLS: 30.37 (-0.07), AET: 89.59 (+0.14), ENR: 132.20 (-0.04), ZTS: 43.84 (+0.87), AGN: 210.12 (+0.95), V: 267.63 (+2.37), GMO: 0.41 (+0.06), RIG: 18.77 (-0.37), EBAY: 57.10 (-0.12), THC: 52.44 (+1.06), BAX: 74.45 (-0.04), CHK: 19.84 (-0.45), AAL: 51.43 (+1.22), GM: 33.43 (-0.13), IDIX: 24.50 (+0.05), MA: 87.77 (+0.14)
United States Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry Analytics 2014-2021 - Market to reach $39.5 billion by 2021
M2 - Mon Dec 15, 8:24AM CST
Research and Markets (http://www.researchandmarkets.com/research/s847lc/vaccines_skin) has announced the addition of Plunkett Research Ltd's new report "Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.) to reach $39.5 billion by 2021 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked - Anika Therapeutics Inc - CSL Behring LLC - Emergent BioSolutions Inc - Halozyme Therapeutics Inc - LifeCell Corporation - Lifecore Biomedical Inc - MiMedx Group Inc - Organogenesis Inc - RTI Biologics Inc - Zoetis Inc For more information visit http://www.researchandmarkets.com/research/s8...cines_skin Source: Plunkett Research Ltd
ZTS: 43.84 (+0.87), RTIX: 5.20 (unch), HALO: 9.34 (+0.31), EBS: 27.64 (+1.28), ANIK: 38.26 (+0.73), MDXG: 11.17 (+0.17)
Veterinary Diagnostics Market worth $4,200 Million by 2018 - Prominent Players in this Market - Heska Corporation (U.S.), Zoetis Inc. (U.S.) & Mindray Medical (China)
M2 - Wed Dec 10, 3:47AM CST
Veterinary diagnostics tests are carried out for the detection of various diseases in animals. These procedures are executed through various methods that use blood, feces, and tissue samples from animals. Based on the type of animals, market is classified mainly into two types, namely, companion animal and food-producing animal. The companion animal ownership has grown over the years and is still on the rise.
ZTS: 43.84 (+0.87)
This Could Be the Next Big Pharma Buyout
Motley Fool Staff - Motley Fool - Mon Dec 08, 9:05AM CST
In a bid to offset the risk of patent expiration, drugmakers spend billions of dollars every year on acquisitions to bolster drug pipelines and boost sales. But just because we know that Big Pharma has a penchant for purchases doesn't mean we know...
ZTS: 43.84 (+0.87), MDVN: 99.23 (+1.23), VRX: 140.33 (-0.22), SHPG: 209.29 (+0.07), PFE: 31.42 (-0.03), LLY: 70.16 (+0.42), ABBV: 66.21 (+1.86), BMY: 59.15 (-0.01)
Why 2014 Is the Biggest Year for Deals Since the Financial Crisis
at The Street - Mon Dec 08, 5:10AM CST
U.S. M&A jumped 38% in the first 10 months of the year from a year earlier, and is likely to mark the strongest year for deals since 2008 financial crisis.
ACT: 254.20 (-1.68), TERP: 29.40 (-0.09), MDT: 74.08 (+0.31), CHTR: 167.46 (-0.31), TWX: 85.58 (-0.20), AGN: 210.12 (+0.95), T: 33.96 (-0.07), FOX: 37.33 (+0.02), EBAY: 57.10 (-0.12), DTV: 86.82 (-0.05), JDSU: 14.01 (+0.13), GTIV: 19.07 (unch), WAG: 76.67 (+0.16), BHI: 56.34 (-0.10), KND: 18.21 (+0.11), ABT: 45.70 (-0.02), EXC: 37.85 (+0.61), COV: 103.35 (+0.57), HAL: 39.70 (-0.18), TSN: 40.33 (-0.90), HPQ: 40.54 (+0.18), SYMC: 26.58 (+0.13), ZTS: 43.84 (+0.87), POM: 26.89 (+0.16), SUNE: 19.50 (+0.01), GIS: 54.31 (-0.10), PETM: 81.16 (+0.03)
The 3 Most Memorable Moments in Healthcare This Year
Motley Fool Staff - Motley Fool - Sun Dec 07, 2:02PM CST
Source: Bill Ackman via Insider Monkey Investors owning healthcare stocks may be sad to see 2014 come to an end. The S&P healthcare index performance more than doubled the S&P 500 return, and biotechnology stocks have been among the...
ZTS: 43.84 (+0.87), AGN: 210.12 (+0.95), VRX: 140.33 (-0.22), ACT: 254.20 (-1.68), SRPT: 13.88 (+0.47), PFE: 31.42 (-0.03), AZN: 70.44 (+0.26)
This Pet Food Supplier Is Still In the Hunt for Growth
Rich Duprey, The Motley Fool - Motley Fool - Thu Dec 04, 9:45AM CST
Pet supplies retailers are moving online to bolster sales. Photo: Flickr via Mike Mozart The kennel is getting smaller as pet industry growth is being fueled by consolidation . Privately held pet supplies retailer Petco just announced it was...
ZTS: 43.84 (+0.87), AMZN: 303.03 (-3.26), ABT: 45.70 (-0.02), PETS: 14.23 (+0.08), PFE: 31.42 (-0.03), WMT: 86.43 (-0.23), PETM: 81.16 (+0.03)